Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis

Detalhes bibliográficos
Autor(a) principal: Estarreja, João
Data de Publicação: 2023
Outros Autores: Mendes, Priscila, Silva, Carina, Camacho, Pedro, Mateus, Vanessa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.21/16721
Resumo: [This corrects the article DOI: 10.2196/38658.]
id RCAP_b99354e88662ad940c1389b43817ac0a
oai_identifier_str oai:repositorio.ipl.pt:10400.21/16721
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysisOphthalmologyAge-related macular degenerationBevacizumabDrug therapynAMDNeovascular age-related macular degenerationWet macular degeneration[This corrects the article DOI: 10.2196/38658.]RCIPLEstarreja, JoãoMendes, PriscilaSilva, CarinaCamacho, PedroMateus, Vanessa2023-12-17T18:17:55Z2023-122023-12-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.21/16721engEstarreja J, Mendes P, Silva C, Camacho P, Mateus V. Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis. JMIR Res Protoc. 2023;12:e50411.10.2196/50411info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-20T02:15:57Zoai:repositorio.ipl.pt:10400.21/16721Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:55:17.852022Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
title Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
spellingShingle Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
Estarreja, João
Ophthalmology
Age-related macular degeneration
Bevacizumab
Drug therapy
nAMD
Neovascular age-related macular degeneration
Wet macular degeneration
title_short Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
title_full Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
title_fullStr Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
title_full_unstemmed Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
title_sort Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
author Estarreja, João
author_facet Estarreja, João
Mendes, Priscila
Silva, Carina
Camacho, Pedro
Mateus, Vanessa
author_role author
author2 Mendes, Priscila
Silva, Carina
Camacho, Pedro
Mateus, Vanessa
author2_role author
author
author
author
dc.contributor.none.fl_str_mv RCIPL
dc.contributor.author.fl_str_mv Estarreja, João
Mendes, Priscila
Silva, Carina
Camacho, Pedro
Mateus, Vanessa
dc.subject.por.fl_str_mv Ophthalmology
Age-related macular degeneration
Bevacizumab
Drug therapy
nAMD
Neovascular age-related macular degeneration
Wet macular degeneration
topic Ophthalmology
Age-related macular degeneration
Bevacizumab
Drug therapy
nAMD
Neovascular age-related macular degeneration
Wet macular degeneration
description [This corrects the article DOI: 10.2196/38658.]
publishDate 2023
dc.date.none.fl_str_mv 2023-12-17T18:17:55Z
2023-12
2023-12-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.21/16721
url http://hdl.handle.net/10400.21/16721
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Estarreja J, Mendes P, Silva C, Camacho P, Mateus V. Correction: The efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis. JMIR Res Protoc. 2023;12:e50411.
10.2196/50411
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136439475109888

Registros relacionados